You are here

  • Home
  • Archive
  • Volume 5, Issue 9
  • Immunogenicity and safety of early vaccination with two doses of a combined measles-mumps-rubella-varicella vaccine in healthy Indian children from 9 months of age: a phase III, randomised, non-inferiority trial

Citation Tools

Article menu
XML
Paediatrics
Research
Immunogenicity and safety of early vaccination with two doses of a combined measles-mumps-rubella-varicella vaccine in healthy Indian children from 9 months of age: a phase III, randomised, non-inferiority trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Lalwani S, Chatterjee S, Balasubramanian S, et al
Immunogenicity and safety of early vaccination with two doses of a combined measles-mumps-rubella-varicella vaccine in healthy Indian children from 9 months of age: a phase III, randomised, non-inferiority trial
BMJ Open 2015;5:e007202. doi: 10.1136/bmjopen-2014-007202